ClinicalTrials.gg
RecruitingNCT06233513Updated Oct 26, 2026

Vowel Space Expansion Sensorimotor Adaptation

An interventional study of Exp 3 Speaking Task in Speech, sponsored by University of Wisconsin, Madison. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-26.

Sponsored by University of Wisconsin, Madison · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Started Feb 2024; still recruiting 2 years 8 months later.
Updated Oct 26, 2026Primary completion movedStudy completion movedGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
117
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this research study is to understand how the brain processes and controls speech in healthy people. The investigators are doing this research because it will help identify the mechanisms that allow people to perceive their own speech errors and to learn new speech sounds. 117 participants will be enrolled into this part of the study and can expect to be on study between 1 day (Experiment 1) and 4 weeks (Experiment 2).

Read the detailed description

The overall study (Establishing the clinical utility of sensorimotor adaptation for speech rehabilitation) aims to understand how cognitive, perceptual, and motor processes are integrated in the control of speech movements. The investigators study how this complex skill is performed in healthy speakers to understand how this system functions, how this skill relates to the perception of speech, and what role different parts of the brain play in this process. Different studies look at how speech motor control is executed, maintained, and changed. Overall, the study will recruit 329 participants over the course of 5 years. Participants can expect to be on study for up to 4 weeks.

The entire study is composed of 8 experiments and 6 interventions. The present record represents Experiments 1-4: 1) Generalization of Vowel Space Expansion to Untrained Words and Vowels; 2) Retention of Vowel Space Expansion After Training in Multiple Sessions; 3) Vowel Space Expansion Training With Connected Speech, and 4)The Relationship Between Acuity, Variability, and Adaptation in Vowels. The paradigms in Experiments 1-3 all involve speech production under conditions of altered auditory feedback, while Experiment 4 is a correlative analysis that compares data from Experiments 1 and 2.

The Experiment 1 paradigm tests how the vowel space expansion induced by sensorimotor adaptation generalizes to untrained items in a single session. Participants will produce four training words (bead, bad, bod, and booed) under a vowel centralization feedback paradigm in which auditory feedback is altered, training them to produce these words with more vowel contrast. In addition to these trained words, eight test items will be produced in pre-training and post-training phases only. We will compare to measure how learning transfers across words that share the same vowel (test words: keep, cap, cop, coop) or whose vowels are intermediate to those of the trained words and which share consonants with the trained words (test words: bid, bud, bade, bode).

The Experiment 2 paradigm tests how the vowel space expansion induced by sensorimotor adaptation is retained over time. Participants will complete eight sessions of the vowel centralization sensorimotor adaptation paradigm over four weeks, producing four training words (bead, bad, bod, and booed) under conditions of altered auditory feedback that train them to produce these words with more vowel contrast. We will measure changes in produced vowels at the start of each session in a baseline phase to assess how much retained across days and weeks.

The Experiment 3 paradigm tests whether vowel space expansion can be evoked by a vowel centralization feedback paradigm applied to running speech (full sentences) rather than single words in healthy speakers. Participants will produce sentences from the Harvard corpus while their speech feedback is altered to centralize vowel feedback. The investigators will measure how working vowel space increases under this paradigm.

Experiment 4 is a correlative analysis which tests whether sensory acuity and speech production variability can predict magnitude of sensorimotor adaptation in interventions 1 and 2. Auditory acuity will be measured through a phoneme discrimination task in which vowel sounds are played to participants over headphones; somatosensory acuity will be measured through a tactile discrimination task in which participants report the orientation (horizontal or vertical) of the gratings on a plastic dome pressed lightly into the tongue. Speech production variability will be measured as the formant variability in the baseline phase of the sensorimotor adaptation experiments in interventions 1 and 2. These measures will be correlated with sensorimotor adaptation magnitude found in the prior interventions.

02

Conditions studied

  • Speech

Browse trials for

Keywords

  • speech motor control
  • vocal learning
03

In context

Speech

205 studies on the registry are indexed under Speech; 80 are open to participants now.

This study's planned enrollment of 117 is above the median of 52 across 141 interventional studies indexed under Speech.

Browse Speech studies →

Lead sponsor

University of Wisconsin, Madison is the lead sponsor of 1,188 studies on the registry; 181 are open to participants now.

Of its 157 completed or terminated interventional studies of FDA-regulated products, 118 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • English-speaking adults
  • normal hearing and speech
  • no history of stroke or neurological conditions

Exclusion criteria

Exclusion Criteria:

  • Native language other than English
  • Any neurological disorders other than the disorder of interest
  • Any history of hearing disorders
  • Uncorrected vision problems that prevent participants from seeing visually-presented stimuli
  • Significant cognitive impairments that prevent participants from carrying out the task or from giving
  • Vulnerable populations (minors and prisoners)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
117 participants (estimated)

Study arms

  • Experimental
    Healthy Adult Speakers

    healthy adult participants across the lifespan in three groups:18-35, 36-55, and 56+

    Behavioral: Exp 3 Speaking Task

Interventions

  • BehavioralExp 3 Speaking Task

    Participant will sit in front of a computer screen in a quiet room and to produce speech based on what is on the screen. Participant may see real words or nonsense words to read. Investigators may play sounds through headphones and ask the participant to repeat them. Participant speech will be recorded by a microphone. This task takes about one hour to complete.

    Also known as: vowel space expansion

06

What researchers measure

Primary outcomes

  1. Average Vowel Spacing (AVS) Measured as the Mean of Pairwise Formant Distances Between Vowels

    AVS is a local measure of vowel spacing.

    Time frame: up to 1 hour (Exp 1,3); eight visits of 1 hour each over 4 weeks (Exp 2)

  2. Quadrilateral Vowel Space Area (qVSA)

    qVSA measures the area (in Hz\^2) between the F1/F2 coordinates of the corner vowels. This is a global measure of working vowel space.

    Time frame: up to 1 hour (Exp 1,3); eight visits of 1 hour each over 4 weeks (Exp 2)

  3. Intelligibility measured by Percent of words correctly identified by 5 independent transcribers

    Intelligibility is a perceptual measure. Four repetitions of each spoken production from each adaptation phase, as well as the minimal-pair neighbors from the calibration phase, will be identified by all transcribers. Because intelligibility in healthy speakers is expected to be near ceiling, speech signals will be masked by speech-shaped noise and delivered at 72 dB over closed-ear headphones. Signal-to-noise ratio will be determined prior to testing as the ratio where, on average, 50% of stimuli in the calibration phase are correctly identified. Transcribers will be native English speakers with no history of neurological/hearing disorders who pass a pure-tone hearing test.

    Time frame: up to 1 hour (Exp 1,3); eight visits of 1 hour each over 4 weeks (Exp 2)

  4. Auditory acuity is measured as the average just noticeable difference (JND) along 4 vowel formant continua

    Auditory acuity is measured as the average just noticeable difference (JND) along 4 vowel formant continua: /i/-/ɪ/, /ɛ/-/æ/, /u/-/ʊ/, and /ɑ/-/ʌ/. Acuity will be measured at continua midpoint (across-category acuity) and at the four corner vowel endpoints (within-category acuity). JNDs will be measured through a 4-interval, 2-alternative forced choice task (AABA or ABAA) via a staircase procedure.

    Time frame: up to 1 hour (Exp 1,3); eight visits of 1 hour each over 4 weeks (Exp 2)

07

Study locations

1 of 1 sites recruiting
08

References and documents

09

Updates

1 registry update since Sep 25, 2026
Primary completion
Oct 2026→Nov 2026
Oct 26, 2026
Study completion
Oct 2026→Nov 2026
Oct 26, 2026
Show all 1 update
  1. Oct 26, 2026
    Primary completion Oct 2026→Nov 2026
    Study completion Oct 2026→Nov 2026
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06233513
Responsible party
Sponsor
First posted
Jan 31, 2024
Start date
Feb 15, 2024
Primary completion
Nov 2026 (estimated)
Completion
Nov 2026 (estimated)
Last update
Oct 26, 2026

Study contacts

Carrie Niziolek, PhD
Contact
cniziolek@wisc.edu
608-890-0192
Carrie Niziolek, PhD
principal investigator · University of Wisconsin, Madison

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion